We are live on ! Find out more
LMDXW

LumiraDx Limited Warrant
LMDXW

Delisted

LMDXW was delisted on the 8th of January, 2024.

Back to rankings

17 hedge funds and large institutions have $5.16M invested in LumiraDx Limited Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less capital invested

Capital invested by funds: $6M → $5.16M (-$847K)

19% less funds holding

Funds holding: 21 → 17 (-4)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
2
Reduced
3
Closed
4
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$174K

Top Buyers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$15.7K
2
CAC
Cowen and Company
New York
+$1.98K
3
WAM
Wolverine Asset Management
Illinois
+$1K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$24.5K
2
SM
Senvest Management
New York
-$24.4K
3
AGM
Alpine Global Management
New York
-$7K
4
HF
HRT Financial
New York
-$3.19K
5
Citadel Advisors
Citadel Advisors
Florida
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVS Health
Rhode Island
$4.82M – – –
LP
2
LMR Partners
United Kingdom
$181K – – –
SM
3
Senvest Management
New York
$122K -$24.4K -178,623 -8%
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$14.5K +$15.7K +115,025 +88%
KL
5
KIM LLC
Kansas
$7K – – –
MCM
6
Moore Capital Management
New York
$3.69K – – –
MI
7
MMCAP International
Cayman Islands
$2.54K – – –
AA
8
Ancora Advisors
Ohio
$2K – – –
Walleye Capital
9
Walleye Capital
New York
$1.77K – – –
CP
10
Covalent Partners
Massachusetts
$1.62K – – –
WAM
11
Wolverine Asset Management
Illinois
$1.32K +$1K +7,323 +48%
Walleye Trading
12
Walleye Trading
New York
$1.18K – – –
CAC
13
Cowen and Company
New York
$855 +$1.98K +14,495 New
BTP
14
Bloom Tree Partners
New York
$605 – – –
Morgan Stanley
15
Morgan Stanley
New York
$220 -$24.5K -179,664 -98%
CAM
16
Cresset Asset Management
Illinois
$3 – – –
AGM
17
Alpine Global Management
New York
– -$7K -64,024 Closed
HF
18
HRT Financial
New York
– -$3.19K -23,345 -61%
Citadel Advisors
19
Citadel Advisors
Florida
– -$2K -18,786 Closed
Verition Fund Management
20
Verition Fund Management
Connecticut
– -$2K -14,495 Closed
UBS Group
21
UBS Group
Switzerland
– -$1K -6,276 Closed

LMDXW Hedge Fund Activity: Q4 2022 in Review

17 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Warrant (LMDXW) for Q4 2022, worth a combined $5.16M — down 14% from $6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LMDXW and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Balyasny Asset Management, adding an estimated $15.7K. The largest seller was Morgan Stanley, cutting an estimated $24.5K.

  • 17 institutional investors held LumiraDx Limited Warrant (LMDXW) as of Q4 2022, down from 21 in Q3 2022.
  • Funds reported $5.16M of LumiraDx Limited Warrant stock for Q4 2022, down 14% quarter-over-quarter.
  • 1 fund opened new LumiraDx Limited Warrant positions in Q4 2022 and 4 closed out, a net change of -3 holders.
  • The largest LumiraDx Limited Warrant buyer in Q4 2022 was Balyasny Asset Management, an estimated $15.7K added.
  • The largest LumiraDx Limited Warrant seller in Q4 2022 was Morgan Stanley, an estimated $24.5K sold.

Based on aggregated 13F filings for Q4 2022.